Phase 3 Clinical Trial for the Combination of Erlotinib plus Ramucirumab Compared with Osimertinib in Previously Untreated Advanced or Recurrent Non–Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L)

2021 ◽  
Author(s):  
Naoki Haratake ◽  
Hidetoshi Hayashi ◽  
Mototsugu Shimokawa ◽  
Yusuke Nakano ◽  
Koichi Azuma ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
L858r Mutation

scholarly journals Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer

2021 ◽  
Author(s):  
Yasuto Yoneshima ◽  
Satoshi Morita ◽  
Masahiko Ando ◽  
Atsushi Nakamura ◽  
Shunichiro Iwasawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Previously Treated

scholarly journals Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial

Lung Cancer ◽  
2021 ◽  
Vol 153 ◽  
pp. 165-170
Author(s):  
Fabio Gomes ◽  
Corinne Faivre-Finn ◽  
Hitesh Mistry ◽  
Andrea Bezjak ◽  
Nicolas Pourel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Secondary Analysis ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 3 ◽  
Limited Stage

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

1994 ◽  
Vol 12 (3) ◽  
pp. 243-249 ◽  
Author(s):  
Dong M. Shin ◽  
Paul Y. Holoye ◽  
Arthur Forman ◽  
Rodger Winn ◽  
Roman Perez-Soler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase Ii Clinical Trial ◽  
Didemnin B ◽  
Small Cell Lung ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document